Delivery Order SPE2DB22D3004-SPE2DB24FNL89

Award Date 11/15/23
Potential Completion Date 11/16/23
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $22,603.51, is for the delivery of VALSARTAN-HCTZ 320-25 MG TAB 90S, a cardiovascular medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 6, 2025. The contract is not designated with any set-aside requirements, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,408.14, is a Delivery Order for the supply of VALSARTAN-HCTZ 160-12.5 MG TAB 90S, a cardiovascular medication. The contract has an ultimate completion date of December 10, 2024, and is a Firm Fixed Price contract. This award is not associated with a set-aside program. In addition to this...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $9,597.58, is for a delivery order to supply VALSARTAN-HCTZ 160-25 MG TAB 90S, a cardiovascular medication, to support federal healthcare programs. The contract has a firm fixed price and an ultimate completion date of December 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $5,893.69, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VALSARTAN-HCTZ 320-12.5 MG TAB 90S, a cardiovascular medication, with a completion date of January 13, 2025. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,546.25 firm-fixed-price delivery order is for the supply of VALSARTAN-HCTZ 160-12.5 MG TAB 90S, a cardiovascular medication, with a completion date of February 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award, valued at $8,014.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VALSARTAN-HCTZ 320-12.5 MG TAB 90S, a cardiovascular medication, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a completion date of January 14, 2025. This award is associated with a larger Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VALSARTAN-HCTZ 320-25 MG TAB 90S, a cardiovascular medication, with a ceiling value of $8,914.46. The contract is a Firm Fixed Price Delivery Order type, with a period of performance ending on January 23, 2024. Amerisourcebergen holds a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,107.24 delivery order contract is for the supply of VALSARTAN-HCTZ 320-12.5 MG TAB 90S, a cardiovascular medication. The contract has a firm fixed price pricing type and an ultimate completion date of May 22, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a $4,618.49 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VALSARTAN-HCTZ 320-25 MG TAB 90S, a cardiovascular medication, with a period of performance through March 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,129.42, is for the delivery of VALSARTAN-HCTZ 320-25 MG TAB 90S, a pharmaceutical product. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of April 2, 2025. The contract is not set aside for any specific business type. AmerisourceBergen...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB24FNL89
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $3,254.40 for the provision of VALSARTAN-HCTZ 320-25 MG TAB 90S, a cardiovascular medication. The contract has an ultimate completion date of November 16, 2023 and is a Firm Fixed Price arrangement. This award is a part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/12/25, 10:14 AM